## Core Concept
Antifibrinolytic agents are drugs that inhibit the process of fibrinolysis, which is the breakdown of blood clots. These agents work by inhibiting plasmin, an enzyme involved in the dissolution of fibrin clots. They are used clinically to prevent excessive bleeding in conditions such as hemophilia or during surgeries.

## Why the Correct Answer is Right
Tranexamic acid (Option C) is a synthetic derivative of lysine and acts as an antifibrinolytic agent by inhibiting plasminogen activation to plasmin, which then cannot bind to fibrin and cause clot breakdown. This mechanism makes tranexamic acid effective in reducing bleeding.

## Why Each Wrong Option is Incorrect
- **Option A:** Aspirin is an antiplatelet agent that works by inhibiting the enzyme cyclooxygenase (COX), which is necessary for the production of thromboxane A2, a potent stimulator of platelet aggregation. It does not act as an antifibrinolytic agent.
- **Option B:** Heparin is an anticoagulant that enhances the activity of antithrombin III, leading to the inhibition of thrombin and factor Xa. It promotes anticoagulation rather than inhibiting fibrinolysis.
- **Option D:** Streptokinase is a thrombolytic agent used to dissolve blood clots. It works by activating plasminogen to plasmin, which then breaks down fibrin clots, making it the opposite of an antifibrinolytic agent.

## Clinical Pearl / High-Yield Fact
A key clinical use of tranexamic acid is in the management of heavy menstrual bleeding and in orthopedic surgeries to reduce blood loss. It's also used in trauma cases to reduce mortality associated with bleeding. A critical point to remember is that tranexamic acid is particularly useful in situations where clot stability is desired.

## Correct Answer: C. Tranexamic acid